APA (7th ed.) Citation

Price, M. Z., & Price, R. L. (2023). Authors' Reply to Pande et al. Comment on "Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder". CNS Drugs, 37(10), 939. https://doi.org/10.1007/s40263-023-01035-2

Chicago Style (17th ed.) Citation

Price, Maxwell Z., and Richard L. Price. "Authors' Reply to Pande Et Al. Comment on "Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder"." CNS Drugs 37, no. 10 (2023): 939. https://doi.org/10.1007/s40263-023-01035-2.

MLA (9th ed.) Citation

Price, Maxwell Z., and Richard L. Price. "Authors' Reply to Pande Et Al. Comment on "Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder"." CNS Drugs, vol. 37, no. 10, 2023, p. 939, https://doi.org/10.1007/s40263-023-01035-2.